Miglustat (Zavesca)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Miglustat (Zavesca), covering 2011-08-10 to 2025-09-09. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of Subjects With Batten Ceroid Lipofuscinosis, Neuronal 3 (CLN3) Disease [Phase 1, Phase 2]